Parvovirus B19 IgG

The Parvovirus B19 IgG (Recombinant) Enzyme Immunoassay Kit measures IgG-class antibodies to Parvovirus B19 in serum.


Catalog No Size
Product Catalog No: EIA-3503 Pack Size: 96 Wells

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Test Principle

The DRG Parvovirus B19 IgG (Recombinant) ELISA Kit is a solid phase enzyme-linked immunosorbent assay (ELISA) Microtiter wells as a solid phase are coated with recombinant Parvovirus B19 antigen (VP1 proteins). Diluted sample specimens and ready-for-use controls are pipetted into these wells. During incubation Parvovirus B19- specific antibodies of high specimens and controls are bound to the immobilized antigens. After a washing step to remove unbound sample and control material horseradish peroxidase conjugated anti-human IgG antibodies are dispensed into the wells. During a second incubation this anti-IgG conjugate binds specifically to IgG antibodies resulting in the formation of enzyme-linked immune complexes. After a second washing step to remove unbound conjugate the immune complexes formed (in case of high results) are detected by incubation with TMB substrate and development of a blue color. The blue color turns into yellow by stopping the enzymatic indicator reaction with sulfuric acid. The intensity of this color is directly proportional to the amount of Parvovirus B19-specific IgG antibody in the sample specimen. Absorbance at 450 nm is read using an ELISA microtiter plate reader.

Order Enquiry

Order Enquiry Form

References
  • Tino F. Schwarz and Gundula Jäger: A recombinant immunoblot and Elisa for detection of acute Parvovirus B 19 infection Zbl. Bakt. 1994, 280, 526-533
  • Maria Söderlund, Caroline S. Brown, Willy J. M. Spaan, Lea Hedman and Klaus Hedman, Epitope type-specific IgG response to capsid proteins VP1 and VP2 of human Parvovirus B19. The Journal of infectious Deseases 1995, 72, 1431-1436
  • P. Cassinotti, Human Parvovirus B19 infections and their diagnosis Alpe Adria Microbiologiy Journal 1995, 4, 235-246 4.
  • M. Schleuning, Parvovirus B19 Infektionen Deutsches Ärzteblatt 93, Heft 43, (Oktober 1996), B2182-B2185
  • Andeas von Poblotzki, Anderas Gigler, Bernhard Lang, Hans Wolf and Susanne Modrow: Antobodies to Parvovirus B 19 NS-1 protein in infected individuals. J. Gen. Virology 1995, 76, 519-527
Enquiry